Intimal Hyperplasia in Balloon Dilated Coronary Arteries is Reduced by Local Delivery of the NO Donor, SIN-1 Via a cGMP-Dependent Pathway

BMC Cardiovascular Disorders

Volumn 11, Issue , 2011, Pages

  Harnek, Jan ^a   Zoucas, Evita ^a   de Sá, Valéria P ^a   Ekblad, Eva ^a   Arner, Anders ^b   Stenram, Unne ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Angioplasty; Endothelium derived factors; Nitric oxide; Remodeling; Restenosis

Indexed keywords

1 H (1,2,4)OXADIAZOLE(4,3 ALPHA)QUINOXALINE 1 ONE; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; LINSIDOMINE; MYOSIN; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; UNCLASSIFIED DRUG; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; ACTIN; DRUG DERIVATIVE; ENZYME INHIBITOR; MOLSIDOMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; NITRIC OXIDE DONOR; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ACTIN FILAMENT; ANGIOCARDIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON DILATATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG ADMINISTRATION ROUTE; DRUG TARGETING; ENDOTHELIUM; ENZYME INHIBITION; INTERMEDIATE FILAMENT; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY; ANALYSIS OF VARIANCE; ANIMAL; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; HYPERPLASIA; INTIMA; METABOLISM; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RESTENOSIS; SIGNAL TRANSDUCTION; SWINE; TIME;

ACTINS; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; CYCLIC GMP; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; GUANYLATE CYCLASE; HYPERPLASIA; INTERMEDIATE FILAMENTS; MOLSIDOMINE; MYOSINS; NAD(P)H DEHYDROGENASE (QUINONE); NADP; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; OXADIAZOLES; QUINOXALINES; SIGNAL TRANSDUCTION; SUS SCROFA; TIME FACTORS; TUNICA INTIMA;

EID: 79958087169     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-11-30     Document Type: Article

References (39)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874. 10.1038/nature01323, 12490960.
2. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424. 10.1152/physrev.00029.2006, 2248324, 17237348.
3. Sarkar K, Sharma SK, Sachdeva R, Romeo F, Mehta JL. Coronary artery stenosis: vascular biology and emerging therapeutic strategies. Expert Rev Cardiovasc Ther 2006, 4(4):543-556. 10.1586/14779072.4.4.543, 16918273.
4. Sarkar R, Gordon D, Stanley JC, Webb RC. Dual cell cycle-specific mechanism mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells. Hypertens 1997, 15:275-283.
5. Münzel T. Recent findings on nitrates: their action, bioactivation and development of tolerance. Dtsch Wochensch 2008, 133(44):2277-2282.
6. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ.Res 1999, 84:253-256.
7. Rabkin SW. Nitric oxide-induced cell death in the heart. The role of autophagy. Autophagy 2007, 3(4):347-349.
8. Maxell AJ. Mechanisms of dysfunction of the nitric oxide pathway in vascular disease. Nitric Oxide 2002, 6(2):101-124. 10.1006/niox.2001.0394, 11890735.
9. Shiraki T, Takamura A, Oka T, Saito D. Effect of short-term administration of high dose L-Arginine on restenosis after percutaneous coronary angioplasty. J Cardiol 2004, 44(1):13-20.
10. Yoon J, Wu C, Homme J, Tuch TJ, Wolff RG, Topol EJ, Lincoff AM. Local delivery of nitrix oxide from a eluting stent to inhibit neointimal thickening in a porcine coronary injury model. Yonsei Medical Journal 2002, 43(2):242-251.
11. Lablanche J-M, Grollier G, Lusson J-R, et al. Effect of direct nitric oxide donors Linsidomine and Molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD study. Circulation 1997, 95(1):83-89.
12. Wohrle J, Hoher M, Nusser T, Kocks M. No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis after percutaneous coronary angioplasty: a randomized, placebo controlled double-blind trial. Can J Cardiol 2003, 19(5):495-500.
13. Baek SH, Hrabie JA, Keefer LK, Hou D, Fineberg N, Rhoades R, March KL. Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty. Circulation 2002, 105:2779-2784. 10.1161/01.CIR.0000017432.19415.3E, 12057994.
14. Harnek J, Zoucas E, Sjuve R, Arner A, Ekblad E, Schou H, Perez de Sà V, Stenram U. Local infusion of the NO donor SIN-1 after angioplasty reduces intimal hyperplasia in porcine coronary arteries. Acta Radiol 2003, 44(4):395-402.
15. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526. 10.1038/327524a0, 3495737.
16. Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 1993, 87:590-597.
17. Furlong B, Henderson AM, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br. J. Pharmcol 1987, 90(4):687-692.
18. Malmqvist U, Arner A. Isoform distribution and tissue content of contractile and cytoskeletal proteins in hypertrophied smooth muscle from rat portal vein. Circ. Res 1990, 66(3):832-845.
19. Hope B, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 1991, 88:2811-2814. 10.1073/pnas.88.7.2811, 51329, 1707173.
20. Nugent HM, Rogers C, Edelman ER. Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res 1999, 84:384-391.
21. Bonan R, Paiement P, Scortichini D, Cloutier MJ, Leung TK. Coronary restenosis: Evaluation of a restenosis injury index in a swine model. Am Heart J 1993, 126(6):1334-1340. 10.1016/0002-8703(93)90531-D, 8249790.
22. Lee KW, Norell MS. Management of "no-reflow" complicating reperfusion therapy. Acute Card Care 2008, 10(1):5-14. 10.1080/17482940701744318, 18449813.
23. Pilz RB, Catsteel DE. Regulation of gene expression by cGMP. Circ Res 2003, 93:1034-1046. 10.1161/01.RES.0000103311.52853.48, 14645134.
24. Rudic RD, Shesely EG, Nobuyo M, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium derived Nitric Oxide in vascular remodeling. J.Clin.Invest 1998, 101(4):731-736. 10.1172/JCI1699, 508619, 9466966.
25. Gratton JP, Bernatchez P, Sessa WC. Caveola and calveolins in the cardiovascular system. Circ.Res 2004, 94:1408-1417. 10.1161/01.RES.0000129178.56294.17, 15192036.
26. Shen YH, Wang XL, Wilken DE. Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett 1998, 433(1-2):125-131. 10.1016/S0014-5793(98)00844-8, 9738946.
27. Brüne B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur.J.Pharmacol 1998, 351:261-272. 10.1016/S0014-2999(98)00274-X, 9721017.
28. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: The good, the bad and the ugly. Am.J.Physiol 1996, 271:C1424-1437.
29. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J.Biol.Chem 1991, 266(7):4244-4250.
30. Kaji T, Kaieda I, Hisatsune T, Kaminogawa S. 3-Morpholinosydnonimine hydrochloride induces p53-dependent apoptosis in murine primary neural cells: A critical role for p21ras-MAPK-p19ARF pathway. Nitric Oxide 2002, 6(2):125-134. 10.1006/niox.2001.0389, 11890736.
31. Kocher O, Gabbiani G. Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells. Hum Pathol 1986, 17(9):875-880. 10.1016/S0046-8177(86)80637-2, 3759072.
32. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest 1984, 73(1):148-152. 10.1172/JCI111185, 424985, 6690475.
33. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8(4):403-409. 10.1038/nm0402-403, 11927948.
34. Ursell PC, Mayes M. Anatomic distribution of nitric oxide synthetase in the heart. Int J Cardiol 1995, 50(3):217-223. 10.1016/0167-5273(95)02380-F, 8537144.
35. Persson K, Poljakovic M, Johansson K, Larsson B. Morphological and biochemical investigation of nitric oxide synthetase and related enzymes in the rat and pig urothelium. J Histochem Cytochem 1999, 47(6):739-750. 10.1177/002215549904700603, 10330450.
36. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, Zalewski A. Increased NAD(P)H oxidase and reactive species in coronary arteries after balloon injury. Arterioscler Tromb Vasc Biol 2001, 21:739-745.
37. Brüne B, Sandau K, Knethen A. Apoptotic cell death and nitric oxide: activating and antagonistic transducing pathways. Biochemistry (Mosc) 1998, 63(7):817-825.
38. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angiography: pathologic observations in 20 patients. J Am Coll Cardiol 1991, 17(2):433-439. 10.1016/S0735-1097(10)80111-1, 1991900.
39. Mintz GS, Popma JJ, Hong MK, Pichard AD, Kent KM, Satler LF, Leon MB. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol 1996, 78(3A):18-22.